Skip to content

Chris Mason

Chris Mason

Company: AvroBio

Job title: CSO

Bio:

Chris is a Founder and Chief Science Officer at AVROBIO, a clinical-stage, gene therapy company in Cambridge, Massachusetts. He is a clinician-scientist with over 25 years of cell and gene therapy experience including Full Professor of Cell and Gene Therapy in the Advanced Centre for Biochemical Engineering, University College London, UK. He has a multidisciplinary track record, spanning R&D, clinical practice, bioprocessing, regulation, healthcare economics, reimbursement and business. Chris is on a number of national and international committees, working groups and initiatives related to the academic, clinical translation and commercialization of cell and gene therapies including; Founder and CEO of the London Regenerative Medicine Network (LRMN), Founding Member of the UK-Israel Science Council, Scientific Advisory Board of the UK Cell and Gene Therapy Catapult, and Strategic Advisory Board of the Canadian Centre for the Commercialization of Regenerative Medicine (CCRM). Chris is Senior Editor of the journals; ‘Cell and Gene Therapy Insights’ and ‘Regenerative Medicine’.

Seminars:

Chair’s Closing Remarks 4:45 pm

Read more

day: Day Two

Chair’s Opening Remarks 7:50 am

Read more

day: Day Two

Chair’s Closing Remarks 7:00 pm

Read more

day: Day One

Chair’s Opening Remarks 7:50 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.